See the source article by following the link below:
New cancer drug Larotrectinib was effective in 93% of pediatric patients tested in a phase 1 clinical trial
New cancer drug Larotrectinib was effective in 93% of pediatric patients tested in a phase 1 clinical trial
No comments:
Post a Comment